TY - JOUR
T1 - The COMiT’ID Study
T2 - Developing Core Outcome Domains Sets for Clinical Trials of Sound-, Psychology-, and Pharmacology-Based Interventions for Chronic Subjective Tinnitus in Adults
AU - Hall, Deborah A.
AU - Smith, Harriet
AU - Hibbert, Alice
AU - Colley, Veronica
AU - Haider, Haúla F.
AU - Horobin, Adele
AU - Londero, Alain
AU - Mazurek, Birgit
AU - Thacker, Brian
AU - Fackrell, Kathryn
AU - for the Core Outcome Measures in Tinnitus (COMiT)
N1 - Funding Information:
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was primarily funded through the NIHR Nottingham Biomedical Research Centre and European Cooperation in Science and Technology Action (BM1306).
Funding Information:
We thank Professor Paula Williamson, University of Liverpool, for commenting on the study protocol; Richard Crew, University of Liverpool, for providing access to the DelphiManager software and for managing the data; and Dr. Sarah Michiels, Dr. Padraig Kitterick, and Dr. Derek Hoare for facilitating the consensus meetings. Participants in the consensus meetings were as follows: sound-based interventions (Remo Arts, Michelle Booth, Peter Byrom, Philippe Fournier, Anna Frost, Claire Gatenby, Michael Golenhofen, Saskia Harden, Steve Harrison, Derek Hoare, Iain MacLeod Brudenell, Ian McCluskey, Jane McFerran, Robert Pierzycki, Penny Peake, Stephanie Polak (Fuller), Margaret Shelton, Rosemary Shippard, Gail Webb); psychology-based interventions (Martin Clarke, Nicolas Dauman, Gwenda Eckersley, Lucy Handscomb, Alan Hopkirk, Laure Jacquemin, Max Millar, Noel Plummer, Helen Pryce, Zofia Pucek, Robert Rainford, Sylvia Roberts, Charlotte Rogers, Jacqui Sheldrake, Jeremy Thomas, Dean Thompson, Barbara White, Darren Wild, Tadeusz Woroniecki); and pharmacology-based interventions (Sandra Bastos, James Blackwell, Benjamin Böcking, Mark Day, Juan Domènech, Jonas Dyhrfjeld-Johnsen, Ralph Holme, Tobias Kleinjung, John Rowley, Carina Santos, Richard Southcott, Thomas Suender, Agnieszka Szczepek, Nuno Trigueiros-Cunha, Paul Van de Heyning, Silvia Zaragoza-Domingo). The COMiT’ID team acknowledges the support of the National Institute for Health Research (NIHR) Clinical Research Network in participant recruitment.
Publisher Copyright:
© The Author(s) 2018.
PY - 2018/11/29
Y1 - 2018/11/29
N2 - Subjective tinnitus is a chronic heterogeneous condition that is typically managed using intervention approaches based on sound devices, psychologically informed therapies, or pharmaceutical products. For clinical trials, there are currently no common standards for assessing or reporting intervention efficacy. This article reports on the first of two steps to establish a common standard, which identifies what specific tinnitus-related complaints (“outcome domains”) are critical and important to assess in all clinical trials to determine whether an intervention has worked. Using purposive sampling, 719 international health-care users with tinnitus, health-care professionals, clinical researchers, commercial representatives, and funders were recruited. Eligibility was primarily determined by experience of one of the three interventions of interest. Following recommended procedures for gaining consensus, three intervention-specific, three-round, Delphi surveys were delivered online. Each Delphi survey was followed by an in-person consensus meeting. Viewpoints and votes involved all stakeholder groups, with approximately a 1:1 ratio of health-care users to professionals. “Tinnitus intrusiveness” was voted in for all three interventions. For sound-based interventions, the minimum set included “ability to ignore,” “concentration,” “quality of sleep,” and “sense of control.” For psychology-based interventions, the minimum set included “acceptance of tinnitus,” “mood,” “negative thoughts and beliefs,” and “sense of control.” For pharmacology-based interventions, “tinnitus loudness” was the only additional core outcome domain. The second step will next identify how those outcome domains should best be measured. The uptake of these intervention-specific standards in clinical trials will improve research quality, enhance clinical decision-making, and facilitate meta-analysis in systematic reviews.
AB - Subjective tinnitus is a chronic heterogeneous condition that is typically managed using intervention approaches based on sound devices, psychologically informed therapies, or pharmaceutical products. For clinical trials, there are currently no common standards for assessing or reporting intervention efficacy. This article reports on the first of two steps to establish a common standard, which identifies what specific tinnitus-related complaints (“outcome domains”) are critical and important to assess in all clinical trials to determine whether an intervention has worked. Using purposive sampling, 719 international health-care users with tinnitus, health-care professionals, clinical researchers, commercial representatives, and funders were recruited. Eligibility was primarily determined by experience of one of the three interventions of interest. Following recommended procedures for gaining consensus, three intervention-specific, three-round, Delphi surveys were delivered online. Each Delphi survey was followed by an in-person consensus meeting. Viewpoints and votes involved all stakeholder groups, with approximately a 1:1 ratio of health-care users to professionals. “Tinnitus intrusiveness” was voted in for all three interventions. For sound-based interventions, the minimum set included “ability to ignore,” “concentration,” “quality of sleep,” and “sense of control.” For psychology-based interventions, the minimum set included “acceptance of tinnitus,” “mood,” “negative thoughts and beliefs,” and “sense of control.” For pharmacology-based interventions, “tinnitus loudness” was the only additional core outcome domain. The second step will next identify how those outcome domains should best be measured. The uptake of these intervention-specific standards in clinical trials will improve research quality, enhance clinical decision-making, and facilitate meta-analysis in systematic reviews.
KW - assessment
KW - patient-reported outcome measures
KW - stakeholder agreement
KW - treatment effectiveness
UR - http://www.scopus.com/inward/record.url?scp=85057532962&partnerID=8YFLogxK
U2 - 10.1177/2331216518814384
DO - 10.1177/2331216518814384
M3 - Article
C2 - 30488765
AN - SCOPUS:85057532962
SN - 2331-2165
VL - 22
JO - Trends in Hearing
JF - Trends in Hearing
ER -